Athanasios K. Anagnostopoulos
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- George Th. TsangarisMeletios Α. DimopoulosSteven P. TreonRobert A. KyleAriadni MavrouKonstantinos VougasSergio GiraltAris Antsaklis
- Journals
- Journal of Proteomics (9 papers)Cancer Genomics & Proteomics (6 papers)Journal of Proteome Research (4 papers)Data in Brief (4 papers)Scientific Reports (3 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Athanasios K. Anagnostopoulos
99 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 113
- Genetics 774
- Pathology and Forensic Medicine 591
- Hematology 316
- Immunology 319
- Nephrology 78
Countries citing papers authored by Athanasios K. Anagnostopoulos
This map shows the geographic impact of Athanasios K. Anagnostopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios K. Anagnostopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios K. Anagnostopoulos more than expected).
Fields of papers citing papers by Athanasios K. Anagnostopoulos
This network shows the impact of papers produced by Athanasios K. Anagnostopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios K. Anagnostopoulos. The network helps show where Athanasios K. Anagnostopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside Athanasios K. Anagnostopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 13 | |
| 13 | 2017 | 21 | |
| 14 | 2017 | 7 | |
| 15 | 2016 | 4 | |
| 16 | 2015 | 14 | |
| 17 | 2012 | 10 | |
| 18 | The proteasome inhibitor, bortezomib, drastically affects inflammation and bone disease in a rat model of adjuvant-induced arthritis | 2009 | 2 |
| 19 | 2007 | 29 | |
| 20 | The Protein Profile of the Human Immature T-cell Line CCRF-CEM. | 2005 | 12 |
About Athanasios K. Anagnostopoulos
Athanasios K. Anagnostopoulos is a scholar working on Genetics, Aging, Pathology and Forensic Medicine, Hematology and Obstetrics and Gynecology, having authored 102 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (15 papers), Ubiquitin and proteasome pathways (12 papers), Prenatal Screening and Diagnostics (10 papers), Advanced Proteomics Techniques and Applications (8 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Probiotics and Fermented Foods (7 papers) and Protein Hydrolysis and Bioactive Peptides (7 papers). The work is most often cited by research in Genetics (774 citations), Pathology and Forensic Medicine (591 citations), Hematology (316 citations), Immunology (319 citations) and Nephrology (78 citations). Athanasios K. Anagnostopoulos has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include George Th. Tsangaris, Meletios Α. Dimopoulos, Steven P. Treon, Robert A. Kyle, Ariadni Mavrou, Konstantinos Vougas, Sergio Giralt, Aris Antsaklis, Aggeliki Kοlialexi and Michael Fountoulakis. Their work appears in journals such as Journal of Proteomics, Cancer Genomics & Proteomics, Journal of Proteome Research, Data in Brief and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.